Home Search

epidiolex - search results

If you're not happy with the results, please do another search
Epidiolex sales - cannabidiol

Epidiolex A Cash Machine For GW Pharmaceuticals

GW Pharmaceuticals estimates its net product sales for 2020 to have reached approximately USD $526 million - and its cannabidiol medicine made up the...
The cost of Epidiolex

The Crazy-High Price Of Cannabidiol Medicine Epidiolex

If parents of children with severe epilepsy were hoping for a bit of compassion on the cost of the first FDA approved cannabis medicine,...
Cannabidiol labelling accuracy

CBD Product Label Accuracy In The Spotlight Again

Yet another study has indicated many manufacturers of unregulated cannabidiol products need to lift their game on quality control. Researchers from the University of Kentucky...
GW Pharmaceuticals

New GW Pharma Facility Construction Kicks Off

GW Pharmaceuticals' parent has announced construction of a new major cannabinoid manufacturing facility at the UK's Kent Science Park has commenced. GW Pharma is the...
Epidyolex approved for tuberous sclerosis complex (TSC) in the UK

CBD Medicine Given TSC Green Light In The UK

Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...
GW Pharmaceuticals

GW Pharma Receives Queen’s Award For Cannabinoid Work

In what may be a first for a medical cannabis company, GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in the Innovation...
Jazz Pharmaceuticals and GW Pharma

Jazz Pharmaceuticals To Acquire GW Pharma

Jazz Pharmaceuticals is to acquire cannabinoid medicine manufacturer GW Pharmaceuticals for a whopping sum. Founded in 1998, GW Pharmaceuticals manufactures CBD-based Epidiolex, which is marketed...
US FDA and cannabidiol

US FDA Outlines Plans For Collecting Better Cannabidiol Data

The U.S. Food and Drug Administration is still inching its way towards developing consumer protection standards relating to CBD. Back in 2019, it appears it...
Canopy Growth vs. GW Pharmaceuticals

Cannabidiol CO2 Extraction Patent Action Launched

Canada's Canopy Growth is taking on the UK's GW Pharmaceuticals over a widely used cannabidiol extraction method. The company recently filed its complaint in the...
Brexit and medicinal cannabis in the UK

Brexit’s Medical Cannabis Sting For UK Paediatric Patients

The UK’s Brexit transition period ends on 1 January 2021, and with it access to medical cannabis prescriptions filled in the EU. From January 1,...
Hemp Seed